-+ 0.00%
-+ 0.00%
-+ 0.00%

Stephens & Co. Reiterates Overweight on CareDx, Maintains $40 Price Target

Benzinga·05/05/2025 13:13:32
Listen to the news
Stephens & Co. analyst Mason Carrico reiterates CareDx (NASDAQ:CDNA) with a Overweight and maintains $40 price target.